Therapeutic application of prazosin in chronic refractory congestive heart failure: Tolerance and “tachyphylaxis” in perspective
- 31 July 1981
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 71 (1), 153-160
- https://doi.org/10.1016/0002-9343(81)90283-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failureThe American Journal of Cardiology, 1979
- Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart FailureAnnals of Internal Medicine, 1979
- Development of systemic vasodilator tolerance to prazosin with chronic use of the agent in ambulatory therapy of severe congestive heart failureThe American Journal of Cardiology, 1978
- Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.Cell Metabolism, 1978
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Cell Metabolism, 1977
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- Effects of prazosin on forearm resistance and capacitance vesselsCancer Cell, 1977
- The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.JCI Insight, 1976
- Renin relationships in congestive cardiac failure, treated and untreatedAmerican Heart Journal, 1970
- A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failureJCI Insight, 1968